Success for a research alliance of the University of Bonn, the Technical University of Dresden and the Ludwig Maximilian University of Munich (LMU): The Collaborative Research Center (SFB)/Transregio 237 "Nucleic Acid Immunity" has convinced with its research work of the past four years. The German Research Foundation (DFG) is funding it for another period with around ten million euros. As planned, the function of spokesperson will be transferred from Prof. Dr. Gunther Hartmann of the University of Bonn to Prof. Dr. Veit Hornung of the LMU.

In severe epilepsies, surgical intervention is often the only remedy - usually with great success. While neuropsychological performance can recover in the long term after successful surgery, on rare occasions, unexpected declines in cognitive performance occur. Researchers at the University of Bonn have now been able to show which patients are at particularly high risk for this. Their findings have been published in the journal "Annals of Neurology." They may help identify affected individuals for whom surgery should be avoided. Instead, new treatment prospects are emerging for these patients.  

The World Reputation Ranking, published by the prestigious magazine “Times Higher Education” (THE), has named the University of Bonn as one of the top 100 universities in the world. Its position in the group ranked 91st–100th marks a very strong performance by the University, which has also come an outstanding sixth within Germany.  

Antibiotics are major weapons in the fight against bacterial infections. However, antibiotics are increasingly losing efficacy due to the emergence of antibiotic resistance. Antibiotic resistance is a most serious threat, that besides limiting our option to treat bacterial infections, also restricts modern medical therapies and treatments, such as chemotherapy, transplantation and surgery. 

The program is aimed at resident physicians who are in the middle of their specialist training. The scientific focus is on the connections between diseases of the nervous system and systemic factors. The application is open to physicians already working at the UKB as well as to those who are currently working at another institution but are interested in switching to the UKB. The deadline for submitting applications has been extended to 23.01.2023. Further information on the program and the current call can be found here.

With a total of 13 researchers, the University of Bonn is represented this year in the international ranking "Highly Cited Researchers". According to the creators of the ranking, the individuals on this list of "Highly Cited Researchers" are among the world's most influential one percent of their field.

An international study led by the medical Faculty of the University of Bonn has identified a gene that plays an important role in the development of the human embryo. If it is altered, malformations of various organ systems can result. The gene emerged very early in evolution. It also exists in zebrafish, for example, and performs a similar function there. The results have now been published in the Journal of Medical Genetics.

The human genome harbors large segments that offer no obvious benefit and can potentially even cause disease. Nevertheless, these areas are copied and maintained every time a cell divides, which means a considerable effort and energy cost for the body. What is the evolutionary advantage of preserving these areas? This is the question that virologist and immunologist Prof. Rayk Behrendt from the Cluster of Excellence ImmunoSensation2 at the University of Bonn is addressing. For his research, he now receives the prestigious Consolidator Grant of the European Research Council (ERC). The selected project of the Bonn professor will be funded with about 2 million euros.